Peripheral Arterial Disease Awareness for Minority Populations

Natalie Evans, MD, MS, FAHA, raises awareness for peripheral arterial disease and highlights how minority populations are often disproportionately affected.

EP: 1.Disparities in Cardiovascular Care for Diverse Populations

EP: 2.Innovation vs Access: Supporting Underserved Communities

EP: 3.Exploring Polypharmacy: Adherence, Communication, and Outcomes

EP: 4.Gender-Based Disparities in Cardiovascular Disease

Now Viewing

EP: 5.Peripheral Arterial Disease Awareness for Minority Populations

EP: 6.Community Partnership: Increasing Public Awareness of CVD

EP: 7.Recent Data Reveals Disparities in Cardiovascular Care

EP: 8.Identifying Social Determinants of Health in Cardiovascular Care

EP: 9.Impact of Novel Medications and Out-Of-Pocket Costs in Managing Cardiovascular Disease

EP: 10.Developing Practical Solutions to Improve Cardiovascular Care

EP: 11.Advancing Cardiovascular Care Through Technological Innovation

EP: 12.Desired Technology Innovations to Prevent Cardiovascular Disease

EP: 13.Measuring Implicit Bias

EP: 14.Achieving Equitable Representation in Clinical Studies

EP: 15.Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion

Related Videos

Related Content

Advertisement

February 4th 2025

Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients

Brooke McCormick

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and treatment outcomes.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 3rd 2025

OIG Report Seeks Better Oversight, Records for FDA’s Accelerated Approvals

Mary Caffrey

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has been overlooked. It shows the need for reforms of the FDA's accelerated approval process.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 31st 2025

FDA Quietly Removes Draft Guidance on Diversity in Clinical Trials Following Executive Order on DEI

Giuliana Grossi

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or explanation.

January 31st 2025

Variable Levels of Lipoprotein Cholesterol Linked to Dementia

Julia Bonavitacola

Older adults had a higher risk of dementia if they had varied levels of lipoprotein cholesterol.

Related Content

Advertisement

February 4th 2025

Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients

Brooke McCormick

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and treatment outcomes.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 3rd 2025

OIG Report Seeks Better Oversight, Records for FDA’s Accelerated Approvals

Mary Caffrey

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has been overlooked. It shows the need for reforms of the FDA's accelerated approval process.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 31st 2025

FDA Quietly Removes Draft Guidance on Diversity in Clinical Trials Following Executive Order on DEI

Giuliana Grossi

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or explanation.

January 31st 2025

Variable Levels of Lipoprotein Cholesterol Linked to Dementia

Julia Bonavitacola

Older adults had a higher risk of dementia if they had varied levels of lipoprotein cholesterol.